|
PFAS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.17879056410675E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.3233999451856E-09 |
| Normal-vs-Stage2 |
1.493970E-02 |
| Normal-vs-Stage3 |
6.104900E-03 |
| Normal-vs-Stage4 |
2.528000E-01 |
| Stage1-vs-Stage2 |
9.086800E-01 |
| Stage1-vs-Stage3 |
7.655800E-01 |
| Stage1-vs-Stage4 |
9.803800E-03 |
| Stage2-vs-Stage3 |
7.703200E-01 |
| Stage2-vs-Stage4 |
9.976500E-02 |
| Stage3-vs-Stage4 |
5.202100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.99018620764491E-12 |
| Normal-vs-AfricanAmerican |
1.77833999999155E-05 |
| Normal-vs-Asian |
4.866200E-01 |
| Caucasian-vs-AfricanAmerican |
1.851810E-01 |
| Caucasian-vs-Asian |
2.984400E-01 |
| AfricanAmerican-vs-Asian |
4.482200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.22110132905595E-11 |
| Normal-vs-Female |
2.01850000047799E-07 |
| Male-vs-Female |
2.682400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.715110E-03 |
| Normal-vs-Extreme_Weight |
1.39330000004101E-06 |
| Normal-vs-Obese |
3.03330000006596E-08 |
| Normal-vs-Extreme_Obese |
2.845600E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.109800E-01 |
| Normal_Weight-vs-Obese |
1.415220E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.221200E-01 |
| Extreme_Weight-vs-Obese |
1.692830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.414400E-01 |
| Obese-vs-Extreme_Obese |
7.092000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.804240E-04 |
| Normal-vs-Age(41-60Yrs) |
3.38018502077375E-12 |
| Normal-vs-Age(61-80Yrs) |
1.24040000049064E-07 |
| Normal-vs-Age(81-100Yrs) |
4.155400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.732350E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.466140E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.679400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.565500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.875840E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.523010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.6269208202857E-12 |
| Normal-VS-Type2 PRCC |
1.255890E-02 |
| Normal-VS-KIRP CIMP |
1.989770E-01 |
| Normal-VS-Unclassified PRCC |
2.28209999999507E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.963100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.843240E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.653400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.720400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.617900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.078000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.330030E-02 |
| Normal-vs-N1 |
5.378100E-03 |
| Normal-vs-N2 |
5.068600E-01 |
| N0-vs-N1 |
4.046000E-01 |
| N0-vs-N2 |
8.863400E-01 |
| N1-vs-N2 |
5.767000E-01 |
|
|
